<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref128">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shalhoub</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Farahat</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Al-Jiffri</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Simhairi</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Shamma</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Siddiqi</surname>
    <given-names>N.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2015</year>). 
  <article-title>IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study</article-title>. 
  <source>J. Antimicrob. Chemother.</source>
  <volume>70</volume>, 
  <fpage>2129</fpage>â€“
  <lpage>2132</lpage>. 
  <pub-id pub-id-type="doi">10.1093/jac/dkv085</pub-id>, PMID: 
  <?supplied-pmid 25900158?>
  <pub-id pub-id-type="pmid">25900158</pub-id>
 </mixed-citation>
</ref>
